Growth and Cost Savings Contributed Significantly to Fourth Quarter Profitability and Cash Flow Building on Year-End Momentum, Company Provides Robust Fiscal 2025 Outlook GRAND RAPIDS, Mich., Feb. 12, 2025 /PRNewswire/ -- Food solutions company SpartanNash (the "Company") (Nasdaq: SPTN) today reported financial results for its 12-week fourth quarter and 52-week fiscal year ended Dec. 28, 2024.

Benchmark initiates coverage of Tesla with a buy rating and $475 price target.

Phase III trial to assess the efficacy and safety of EscharEx ® for debridement and facilitation of active wound closure

Virtual event will bring together thought leaders, industry experts, and visionaries to explore how technology is transforming the ways we live, work, and beyond TROY, Mich. , Feb. 12, 2025 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, is pleased to announce Future.Industry 2025, the company's flagship annual event, which will take place virtually on March 5-6.

HAMILTON, Bermuda , Feb. 12, 2025 /PRNewswire/ -- Nabors Industries Ltd. ("Nabors") (NYSE: NBR) today issued the following statement regarding the entry into a business combination agreement between the special purpose acquisition company Nabors formed in 2023, Nabors Energy Transition Corp. II (NASDAQ: NETD), and e2Companies LLC ("e2"): As a pioneer of an AI-based Virtual Utility ®, e2 delivers a unique offering in the power market.

Figure 1: Lightbridge and INL teams at Idaho National Laboratory RESTON, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Lightbridge) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced a significant milestone in its innovative nuclear fuel development efforts, successfully performing a co-extrusion demonstration of a coupon sample consisting of an alloy of depleted uranium and zirconium with an outer cladding made of nuclear-grade zirconium alloy material at Idaho National Laboratory (INL).

PHILADELPHIA, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Brandywine Realty Trust (NYSE: BDN) today announced a new culinary destination is taking shape at Schuylkill Yards. Gather Food Hall & Bar will bring together six local vendors and an elevated bar, offering a mix of global flavors in a lively, contemporary setting.

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer's disease with MK-1167, an α7 nicotinic acetylcholine receptor positive allosteric modulator Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer's disease with MK-1167, an α7 nicotinic acetylcholine receptor positive allosteric modulator

RIDGEFIELD, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its fourth quarter ended December 27, 2024.

Crocs, Inc. stock has tumbled by nearly 50% since June 2024, underperforming industry peers and the broader stock market. Despite producing lackluster growth numbers in recent quarters, Crocs' strong free cash flow generation (optionality) and strategic investments in brand growth support long-term business potential. Wall Street analysts remain bullish on CROX, with a consensus price target implying ~50% upside and TQI's fair value estimate suggesting +102% potential.

GONZALES, La. , Feb. 12, 2025 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the third quarter fiscal year 2025, which ended December 29, 2024.

MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) reported results for the three months ended December 31 as follows: (In millions, except EPS) Earnings Before Taxes Earnings Diluted Earnings Per Share 2024 2023 2024 2023 2024 2023 Continuing operations (GAAP) $ 181 160 $ 135 124 $ 3.11 2.74 Comparable (non-GAAP) $ 199 172 $ 150 134 $ 3.45 2.95 Total and operating revenue for the three months ended December 31 were as follows: (In millions) Total.

Earnings Growth and Margin Expansion Resumed in the Fourth Quarter Achieved Full-Year Records for Aggregates Revenues, Gross Profit and Unit Profitability Completed Aggregates Bolt-Ons in Florida, Southern California and Texas in the Fourth Quarter RALEIGH, N.C., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta” or the “Company”), a leading national supplier of aggregates and heavy building materials, today reported results for the fourth quarter and year ended December 31, 2024.

Biogen posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer's treatment Leqembi, saw growth. The biotech company issued a full-year 2025 adjusted earnings outlook of $15.25 to $16.25 per share, which fell short of the $16.34 per share that Wall Street was expecting.

WINTER PARK, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors approved a new common stock repurchase program (the “Program”). Under the Program, the Company may acquire shares of the Company's common stock, $0.01 par value per share (“Common Stock”), in the open market, from time to time, in block trades, or otherwise, for a total purchase price of up to $10,000,000. The Program does not require the Company to repurchase any dollar amount or number of shares of Common Stock and may be suspended or …

CHICAGO--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024. "I am pleased to announce Exelon has delivered against our financial goals for the third straight year since becoming a transmission and delivery-only company, and we delivered top quartile performance across all our local energy companies, with ComEd and Pepco Holdings in the top decile," said Exelon President and Chief Executive Officer Calvin Butler. "Our.

- Data Generated to Date Support Potential for Aclaris' ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced the availability of a new publication describing the unique properties of Aclaris Therapeutics' ATI-2138, a novel investigational covalent inhibitor of interleukin-2-inducible T cell kinase (ITK) and Janus kinase 3 (JAK3) in development for the treatment of autoimmune and inflammatory diseases.

Restaurant Brands International reported quarterly adjusted earnings per share of 81 cents and revenue of $2.3 billion. Burger King's and Popeyes' U.S. restaurants outperformed Wall Street's expectations.

Alphabet's Google Cloud grew 30% YoY in Q4'24, with operating margins rising to 17.51%, driven by strong AI and developer adoption. Management plans to deploy $75B in eFY25 to boost compute capacity, supporting further growth in Google Cloud and AI initiatives. Despite capacity constraints, Alphabet's AI tools like Gemini 2.0 and Vertex AI are seeing significant adoption, enhancing internal efficiencies with AI agents automating processes.

Biogen forecast 2025 profit below Wall Street expectations on Wednesday, hurt by a strong dollar and fierce competition for its drugs to treat multiple sclerosis.